Annual EBITDA
$4.22B$957.00M+29.33%
Summary
- Current Value
- As of today, CAH annual EBITDA is $4.22B, up +29.33% on
- Historical Performance
- CAH annual EBITDA is up +70.23% over the past 3 years, up +60.95% over the past 5 years
- All-Time High Comparison
- CAH annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH annual EBITDA is +70.23% above its 3-year low of $2.48B reached on an earlier date
- Sector Comparison
- CAH annual EBITDA is higher than 97.25% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.22B | +29.3% | +70.2% | +61.0% | +108.6% | |
| Quarterly EBITDA | $1.15B | +14.3% | +72.6% | +64.9% | +107.4% | |
| TTM EBITDA | $4.38B | +20.8% | +65.1% | +66.7% | +106.0% | |
| Price | $272.81 | +31.2% | +159.2% | +463.2% | +551.4% | |
| PE Ratio | 50.95 | +62.4% | -72.4% | +307.3% | +211.4% | |
| Annual Revenue | $254.23B | +14.2% | +24.0% | +56.5% | +147.7% | |
| Annual EPS | $7.23 | +12.1% | +474.2% | +248.0% | +165.9% | |
| $3.26B | +32.0% | +82.7% | +79.6% | +90.7% | ||
| Annual Net Income | $1.71B | +8.7% | +415.1% | +178.6% | +76.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.22B | at high | |
| 5Y | $4.22B | at high | |
| All | $4.22B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.48B | N/A | +70.2% |
| 5Y | $2.40B | +76.1% | |
| All | $4.10M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of CAH?
- As of today, CAH annual EBITDA is $4.22B
- What is 1-year change in CAH annual EBITDA?
- CAH annual EBITDA is up +29.33% year-over-year
- What is 3-year change in CAH annual EBITDA?
- CAH annual EBITDA is up +70.23% over the past 3 years
- How far is CAH annual EBITDA from its all-time high?
- CAH annual EBITDA is currently at its all-time high
- How does CAH annual EBITDA rank versus sector peers?
- CAH annual EBITDA is higher than 97.25% of companies in Healthcare sector
- When is CAH next annual earnings release?
- As of today, the next annual earnings release for CAH has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$1.15B$67.00M+6.20%
Summary
- Current Value
- As of today, CAH quarterly EBITDA is $1.15B, up +6.20% on
- Historical Performance
- CAH quarterly EBITDA is up +14.34% year-over-year, up +72.63% over the past 3 years
- All-Time High Comparison
- CAH quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH quarterly EBITDA is +72.63% above its 3-year low of $665.00M reached on an earlier date
- Sector Comparison
- CAH quarterly EBITDA is higher than 96.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.15B | +6.2% | +14.3% | +72.6% | +64.9% | |
| Annual EBITDA | $4.22B | – | +29.3% | +70.2% | +61.0% | |
| TTM EBITDA | $4.38B | +3.4% | +20.8% | +65.1% | +66.7% | |
| Price | $272.81 | +19.4% | +31.2% | +159.2% | +463.2% | |
| PE Ratio | 50.95 | +61.4% | +62.4% | -72.4% | +307.3% | |
| Quarterly Revenue | - | – | – | – | – | |
| Quarterly EPS | $0.00 | -100.0% | -100.0% | +100.0% | -100.0% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Quarterly Net Income | - | – | – | – | – |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.15B | at high | |
| 3Y | $1.15B | at high | |
| 5Y | $1.15B | at high | |
| All | $1.15B | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.00B | N/A | +14.3% |
| 3Y | $665.00M | N/A | +72.6% |
| 5Y | $517.00M | +122.0% | |
| All | -$484.00M | +337.2% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of CAH?
- As of today, CAH quarterly EBITDA is $1.15B
- What is CAH quarterly EBITDA most recent change?
- CAH quarterly EBITDA was up +6.20% on September 30, 2026
- What is 1-year change in CAH quarterly EBITDA?
- CAH quarterly EBITDA is up +14.34% year-over-year
- How far is CAH quarterly EBITDA from its all-time high?
- CAH quarterly EBITDA is currently at its all-time high
- How does CAH quarterly EBITDA rank versus sector peers?
- CAH quarterly EBITDA is higher than 96.73% of companies in Healthcare sector
- When is CAH next earnings release?
- The next earnings release for CAH is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$4.38B$144.00M+3.40%
Summary
- Current Value
- As of today, CAH TTM EBITDA is $4.38B, up +3.40% on
- Historical Performance
- CAH TTM EBITDA is up +20.79% year-over-year, up +65.07% over the past 3 years
- All-Time High Comparison
- CAH TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH TTM EBITDA is +65.07% above its 3-year low of $2.65B reached on an earlier date
- Sector Comparison
- CAH TTM EBITDA is higher than 96.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.38B | +3.4% | +20.8% | +65.1% | +66.7% | |
| Annual EBITDA | $4.22B | – | +29.3% | +70.2% | +61.0% | |
| Quarterly EBITDA | $1.15B | +6.2% | +14.3% | +72.6% | +64.9% | |
| Price | $272.81 | +19.4% | +31.2% | +159.2% | +463.2% | |
| PE Ratio | 50.95 | +61.4% | +62.4% | -72.4% | +307.3% | |
| TTM Revenue | - | – | – | – | – | |
| TTM EPS | $5.35 | -26.0% | -19.2% | +838.8% | +38.4% | |
| $2.51B | -23.5% | -9.9% | +28.0% | +39.1% | ||
| TTM Net Income | - | – | – | – | – |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.38B | at high | |
| 3Y | $4.38B | at high | |
| 5Y | $4.38B | at high | |
| All | $4.38B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.63B | N/A | +20.8% |
| 3Y | $2.65B | N/A | +65.1% |
| 5Y | $2.27B | +93.2% | |
| All | -$96.20M | +4654.1% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of CAH?
- As of today, CAH TTM EBITDA is $4.38B
- What is CAH TTM EBITDA most recent change?
- CAH TTM EBITDA was up +3.40% on September 30, 2026
- What is 1-year change in CAH TTM EBITDA?
- CAH TTM EBITDA is up +20.79% year-over-year
- How far is CAH TTM EBITDA from its all-time high?
- CAH TTM EBITDA is currently at its all-time high
- How does CAH TTM EBITDA rank versus sector peers?
- CAH TTM EBITDA is higher than 96.82% of companies in Healthcare sector
- When is CAH next earnings release?
- The next earnings release for CAH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CAH Official Website www.cardinalhealth.com
- CAH Profile on Yahoo Finance finance.yahoo.com/quote/CAH
- CAH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cah
